(AP) Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that ...

Wegovy (semaglutide) is a weight loss medicine. The FDA first approved Wegovy in 2021 to help people who are overweight or have obesity lose weight and keep it off. In 2024, Wegovy was also approved ...

Stopping Wegovy, especially suddenly, can lead to weight regain, potentially reversing progress made during treatment. Ending Wegovy treatment may also increase cardiovascular risks and raise blood ...

Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking. By Dani Blum Dani Blum met with over a dozen doctors and patients in Ann ...

Eli Lilly said its Zepbound obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in a head-to-head study of the two drugs. Zepbound ...

Wegovy (semaglutide) is a prescription drug used for weight loss and to lower the risk of cardiovascular problems in some people. It’s also used to treat metabolic dysfunction-associated ...

See all the celebrities who've talked about semaglutide and tirzepitide GLP-1 drugs including Ozempic, Mounjaro, Zepbound and ...

A number of patients, including at least three from Long Island, contend they suddenly lost their vision after taking the widely popular weight loss drugs Ozempic and Wegovy, according to a Long ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...